870521-33-8,
2-MORPHOLINOPYRIMIDIN-5-YLBORONIC ACID,
2-Morpholinopyrimidine-5-boronic acid,
(2-morpholinopyrimidin-5-yl)boronic acid,
AK-28696,
2-(Morpholine-4-yl)pyrimidine-5-boronic acid,
Q-103424,
2-morpholinopyrimidin-5-ylboronicacid,
ACMC-209qd5,
C8H12BN3O3,
SCHEMBL5525017,
CTK5F7662,
KS-00000HRT,
DTXSID30676914,
KFYQOIHLZBDFBU-UHFFFAOYSA-N,
ABBYPHARMA AP-30-2753,
BCP23294,
ANW-38439,
MFCD07375148,
AKOS015855906,
ZINC169747237,
AB41290,
CM-1161,
CS-W018736,
RP26475,
AN-26898,
BC001927,
DS-11115,
OR360280,
AX8160526,
DB-013592,
ST2404511,
TR-027096,
4CH-016921,
AM20110249,
FT-0690038,
X1399,
A-3514,
[2-(morpholin-4-yl)pyrimidin-5-yl]boronic acid,
521M338,
2-Morpholinopyrimidin-5-ylboronic acid, AldrichCPR,
Boronic acid, [2-(4-morpholinyl)-5-pyrimidinyl]-,
Boronic acid,B-[2-(4-morpholinyl)-5-pyrimidinyl]-,
I14-8952,
2-(MORPHOLIN-4-YL)PYRIMIDIN-5-YLBORONIC ACID,
B-[2-(4-MORPHOLINYL)-5-PYRIMIDINYL]-BORONIC ACID,
ACN-034293,
A10362,